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Zp3–cre, a transgenic mouse line for the activation or
inactivation of loxP-flanked target genes specifically in the
female germ line
Mark Lewandoski, Karen Montzka Wassarman and Gail R. Martin
The site-specific DNA recombinase Cre is being used to
develop a new generation of tools for controlling gene
expression in mice [1]. Cre mediates the recombination
of two directly repeated target (loxP) sites to a single
loxP site, with concomitant excision of the DNA segment
flanked by the loxP sites (the ‘floxed’ DNA). Such
recombination can function to activate a gene by excising
a floxed DNA segment that blocks expression because it
either separates the regulatory and coding sequences of
the gene [2] or interrupts the gene’s open reading frame.
Conversely, DNA excision can inactivate a gene if an
essential fragment of the gene is floxed [3]. Gene
activation or inactivation in vivo can be achieved by
mating two different animals, one carrying a ‘target gene’
with appropriately placed loxP sites and one carrying a
cre transgene. In most cases, the specificity of the system
is dependent upon stringent regulation of cre expression.
We describe here a mouse line in which cre expression is
controlled by regulatory sequences from the mouse zona
pellucida 3 (Zp3) gene, which is normally expressed
exclusively in the growing oocyte prior to the completion
of the first meiotic division [4]. We show that in target-
bearing Zp3–cre mice, Cre-mediated recombination of
the target gene apparently occurs in 100 % of oocytes.
Moreover, Cre activity is not detected in the somatic
tissues of most target-bearing Zp3–cre mice. Potential
uses for this mouse line are discussed.
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Results and discussion
To construct the pZp3–cre plasmid used to produce trans-
genic mice, we first modified the bacteriophage P1 cre gene
[5] so that the ATG start codon and five bases immediately
upstream of it were replaced by the sequence
CCACCATGGGCCCAAAGAAGAAGGAGAAGGTT.
These changes served to optimize translational efficiency
[6] and to insert the sequence that encodes the nuclear
localization signal from the T antigen of simian virus 40
(SV40) [7] into the 5′ region of the cre open reading frame.
This modified cre DNA was then placed downstream of a
6.5 kilobase (kb) KpnI restriction fragment that contains
Zp3 regulatory regions previously shown to drive expres-
sion of the firefly luciferase reporter gene in an oocyte-spe-
cific manner [8] and upstream of a 0.89 kb HindIII–KpnI
fragment that contains the polyadenylation signal from the
human b-actin gene (K. Sturm and R. Pedersen, personal
communication). The resulting pZp3–cre construct was
injected into mouse zygotes (strain FVB/N) to produce
Figure 1
Mating scheme to assess Cre activity in the female germ line of Zp3–cre
transgenic mice. By crossing Zp3–cre mice with a line of mice carrying
the floxed target gene, female cre+/target+ progeny were obtained. The
cre and target genes segregate independently in these females, and
thus when they are mated to wild-type males, progeny of four different
genotypes are obtained. If cre has been expressed in the oocyte, the
target gene is inherited in the recombined form, regardless of whether
the cre transgene is also inherited. Thus, Cre activity in the female germ
line can be assayed by determining the frequency at which cre+/target+
females transmit the target gene in recombined form.
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transgenic founder mice, and the Zp3–cre mouse line
described here was established. 
Cre activity in the female germ line was assessed using the
mating scheme illustrated in Figure 1. Zp3-cre mice were
mated to mice carrying a floxed target gene, and female
cre+/target+ progeny were selected for further study. As a
target gene we used an endogenous gene, Gbx2, modified
by homologous recombination so that it contains two loxP
sites (Fig. 2a and our unpublished work). Mice hetero-
zygous for either the floxed (non-recombined) Gbx2 allele
or its recombined derivative are phenotypically normal. A
single polymerase chain reaction (PCR) assay, using
primers that hybridize to sequences flanking the loxP sites
in the target gene, distinguishes between non-recombined
and recombined Gbx2 alleles (Fig. 2a). When the substrate
for the PCR is the non-recombined allele, the amplifica-
tion product is a 1.75 kb fragment, whereas when the sub-
strate is the recombined allele it is a 0.25 kb fragment.
When the substrate is wild-type mouse DNA, no amplifi-
cation product is detected, because one of the PCR
primers hybridizes to sequences within the neo expression
cassette that are not present in wild-type DNA. Because
we expected that the smaller fragment representing the
recombined allele would be preferentially amplified, we
were concerned that in DNA from animals carrying both
alleles, the non-recombined allele would be difficult to
detect. However, control experiments showed that the
1.75 kb amplification product could still be detected when
the PCR substrate was DNA containing the non-recom-
bined allele diluted 100-fold with DNA containing the
recombined allele. Conversely, the 0.25 kb amplification
product could still be detected when the ratio of non-
recombined:recombined allele in the DNA was 4000:1
(see Fig. 2b; the band was clearly detectable in the gel).
Tail DNA from 58 progeny of a cross between cre+/target+
females and wild-type males was subjected to PCR analysis
to determine the genotype of each animal. All possible cate-
gories of progeny were obtained in the expected Mendelian
ratios (18 cre+/target –, 15 cre –/target +, 11 cre+/target +, and
14 cre –/target –). This analysis also revealed the recombina-
tion status of the target gene in the 26 target+ offspring (Fig.
2b and data not shown). In each sample, only the 0.25 kb
fragment was detected, whether or not the animal also
carried Zp3–cre. This indicates that recombination occurred
at 100 % efficiency as a consequence of Cre produced in
oocytes. Similar results were obtained when tail DNA from
the progeny of females carrying Zp3–cre and a different
target transgene (a floxed allele of the Fgf8 gene) was
assayed for target recombination (E. Meyers, M.L. and
G.R.M., unpublished observations), indicating that highly
efficient Cre-mediated recombination in the female germ
line is characteristic of our Zp3–cre mouse line and is not
specific to a particular target gene. Preliminary studies in
which the sexes were reversed, and the progeny of
cre+/target+ males were assayed for recombination, indicated
that the Zp3–cre transgene is not active in the male germ
line (data not shown).
These data illustrate one use for which Zp3–cre mice are
ideally suited: the generation at very high efficiency of
progeny that carry the recombined (null) allele of a floxed
target gene (such as Gbx2 or Fgf8). The mouse lines carrying
the non-recombined target gene remain available for future
use in gene inactivation experiments employing mice that
express cre in specific tissues. Two other cre transgenic
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Figure 2
Assay for Cre-mediated DNA recombination in the female germ line.
(a) Diagram of the target gene. The larger boxes represent exons of
the Gbx2 gene and the horizontal line intron DNA. White and grey
shading represent coding and non-coding regions, respectively; the
neo selection cassette was inserted into the intron. The floxed Gbx2
gene (top) contains loxP sites flanking parts of the intron and the 3′
end of the Gbx2 coding region; after Cre-mediated recombination
(bottom), the DNA flanked by loxP sites is deleted and a single loxP
site remains. The horizontal arrows represent primers used in the target
gene PCR assay (5′-CTTGTGTAGCGCCAAGTG-3′ and 5′-
GGTGCCTCTGAGTTCTGC-3′). (b) Assay for recombination status
of the Gbx2 target gene in progeny of a cross between a cre+/target+
female and a wild-type male. Control DNAs from mice carrying either
the non-recombined or recombined target allele were mixed in the
ratios indicated, and used as a substrate for the target gene PCR
assay (left). Right panel, top: tail DNA from individual progeny (1–8)
and control DNAs were used as substrates for the target gene PCR
assay; right panel, bottom: the same progeny DNAs were assayed for
the presence of absence of the cre transgene using primers that
hybridize to the cre gene (5′-TGATGAGGTTCGCAAGAACC-3′ and
5′-CCATGAGTGAACGAACCTGG-3′). Control DNAs were derived
from mice carrying the cre transgene or wild-type mice. In all target+
progeny, the target was inherited in the recombined form, irrespective
of whether the cre transgene was also inherited. 
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mouse lines have been described that can also be used to
obtain offspring with a recombined target gene [9,10]. In the
cre+/target+ animals obtained by mating those cre mice with
target-bearing mice, Cre apparently functions in many cells
at early stages of development, including germ cells or their
precursors. Such cre+/target+ animals may thus be mosaic
with respect to target gene recombination, but they are able
to transmit a recombined target allele to their progeny. 
Other potential uses of the Zp3–cre mice depend not only
on the efficient function of Cre in the female germ line,
but also on the absence of Cre activity in somatic tissues.
To explore this issue, we mated Zp3–cre males with target+
females and assayed for target gene recombination in
various tissues from their cre+/target+ offspring. In prelimi-
nary studies, we found that the recombined allele was not
detectable by Southern-blot analysis of genomic DNA
from the cre+/target+ mice (data not shown). Thus we used
the more sensitive PCR-based assay described above to
determine the recombination status of the target gene in
numerous tissues from four cre+/target+ mice. When DNA
isolated from tissues of two individuals was used as the
substrate for target gene amplification, only the 1.75 kb
fragment representing the non-recombined allele was
detected (Fig. 3a and data not shown). Even when the
PCR amplification products from one of these individuals
were assayed by Southern blot, the 0.25 kb fragment rep-
resenting the recombined allele was not detected (data not
shown). When DNA from the same tissues isolated from
the two other individuals was assayed, similar results were
obtained except that a small amount of the 0.25 kb PCR
amplification product was detected in the tail, brain, and
ear samples from both mice, and also in the uterus and
muscle samples from one of the mice (Fig. 3b and data not
shown). We assayed in this way for target gene recombina-
tion in tail DNA isolated from an additional 19 cre+/target+
mice. In 15/19 samples analyzed, only the 1.75 kb PCR
amplification product representing the non-recombined
allele was detected; in the remaining 4/19 samples both
the 1.75 kb and the 0.25 kb fragments could be seen (data
not shown). Because the control experiments indicate that
the recombined allele can be detected when it constitutes
as little as 0.025 % of the PCR substrate, these data indi-
cate that in most individuals of this Zp3–cre line, expres-
sion of the cre gene is stringently regulated and expressed
only in the female germ line. It should be noted, however,
that in a second mouse line produced with our Zp3–cre
construct, we found evidence of extensive recombination
in somatic tissue from all cre+/target+ mice assayed (n = 13;
data not shown). 
The oocyte specificity of Cre activity in our Zp3–cre mice
makes them a valuable resource for studies aimed at deter-
mining the consequences of transgene expression when
such expression causes lethality or some defect that
precludes the establishment of a transgenic line. In such
experiments, the target transgene (which will function only
after being activated by recombination) could be one that
causes ectopic expression of a normal gene, expression of a
gain-of-function or dominant-negative mutation, or cell
ablation (via toxin-gene expression) in a particular tissue.
By mating Zp3–cre males to females carrying such a target
transgene in the non-recombined (inactive) form, one
would obtain cre+/target+ females that are phenotypically
normal because the target transgene remains non-recom-
bined (inactive) in somatic tissues. However, all the off-
spring of such females that inherit the target transgene will
acquire it in the recombined (activated) form, and as they
develop they will display the mutant phenotype. Thus,
Zp3–cre mice provide a highly efficient means of producing
experimental embryos carrying an activated target gene in
all their cells. In principle, similar results could also be
Figure 3
Assay for Cre-mediated DNA recombination in somatic tissues of
cre+/target+ mice. DNA from the tissues indicated was used as a
substrate for the target gene PCR assay; (a) and (b) show samples
from different individuals. In addition to the 1.75 kb PCR product,
representing the non-recombined target allele, which is detected in all
samples, a small amount of the 0.25 kb PCR product, representing
the recombined allele, can be detected in the lanes containing brain,
ear, and tail DNA from one individual (b). Control DNA samples as in
Figure 2. 
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obtained by mating target animals to mice in which cre is
expressed at a very early stage of development [9,10],
resulting in recombination (target activation) after fertiliza-
tion in individual cells of cre+/target+ progeny. However, if
recombinase activity were not sufficiently high to mediate
target gene recombination in some cells, the embryos
would be mosaic with respect to transgene activation, which
would complicate the analysis of the mutant phenotype. 
Zp3-cre mice are also potentially useful for inactivating
endogenous genes specifically in the oocyte. By such inac-
tivation, one can study the functions of genes that play a
role in oocyte maturation, as well as those whose expres-
sion in the developing oocyte is necessary for develop-
ment of the early embryo. In principle, oocyte-specific
gene inactivation could be achieved by producing Zp3–cre
females that carry both a null and a floxed allele of the
gene of interest, or that are homozygous for the floxed
allele. Recombination of the floxed allele(s) in the oocyte
should result in eggs that are homozygous null for the
gene of interest. This approach would be essential in cases
in which females lacking the gene product in all their
tissues (including oocytes) cannot be obtained because
homozygosity for the null allele is lethal. This approach
can only be used, however, if Cre-mediated recombination
occurs in the oocyte before the gene of interest is
expressed. It seems likely that Cre does indeed function
early in oocyte maturation, prior to completion of the first
meiotic division, because the target allele is always inher-
ited in the recombined form by the progeny of cre+/target+
females irrespective of whether they also inherit the cre
gene. Moreover, the Zp3 regulatory elements used to
control cre gene expression in the Zp3–cre mouse line are
known to drive gene expression in the growing oocyte.
Nevertheless, it is conceivable that the target gene might
be accessible for Cre-mediated recombination only after
fertilization. If that were the case, then inheritance of the
target in the recombined form might occur because Cre
protein produced in the growing oocyte is present in suffi-
ciently high amounts to mediate the recombination of the
inherited target gene after fertilization. 
This possibility can be explored by determining whether
sufficient Cre activity remains in Zp3–cre oocytes to mediate
the recombination of a target gene that has been brought in
by the sperm at fertilization. We therefore mated Zp3–cre
females with target+ males, and assessed the recombination
status of the target gene in tail DNA from their cre– progeny.
Of the 44 progeny analyzed, 10 were found to be of the
genotype of interest (cre–/target+): 4/10 animals carried only
the recombined allele, whereas 6/10 carried the non-recom-
bined allele (3/10 carried only the non-recombined allele,
and 3/10 were mosaic for the two forms of the target gene).
These results contrast sharply with our finding that 15/15
cre–/target+ progeny carried only the recombined form of the
target gene when it was transmitted by cre+/target+ females,
thereby providing strong evidence that, in the Zp3–cre
mouse line, Cre-mediated recombination occurs very early
in oocyte development. These results also indicate that suf-
ficient Cre activity remains in mature oocytes to mediate
the recombination of a paternally contributed target gene, at
least in some cases. This observation is important because it
indicates that to obtain cre+/target+ animals in which the
target gene is not recombined in any cells (except female
germ cells), the parental Zp3–cre gene must be contributed
by the sperm and not by the oocyte. More importantly,
taken together the data indicate that the Zp3–cre mouse line
should be a valuable resource for carrying out oocyte-spe-
cific gene inactivation experiments. For example, two
excellent candidates for this approach are the genes encod-
ing b-catenin and E-cadherin. Both genes are expressed in
the developing oocyte, and it has been proposed that this
maternal expression is required for pre-implantation devel-
opment [11], but this hypothesis cannot be tested using the
standard gene-inactivation approach because embryos
homozygous for null mutations are not viable [12,13]. 
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